These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35952593)

  • 1. Cu
    Wang H; Mörman C; Sternke-Hoffmann R; Huang CY; Prota A; Ma P; Luo J
    J Inorg Biochem; 2022 Nov; 236():111945. PubMed ID: 35952593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Particle Resolution of Copper-Associated Annular α-Synuclein Oligomers Reveals Potential Therapeutic Targets of Neurodegeneration.
    Synhaivska O; Bhattacharya S; Campioni S; Thompson D; Nirmalraj PN
    ACS Chem Neurosci; 2022 May; 13(9):1410-1421. PubMed ID: 35414168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease.
    Dudzik CG; Walter ED; Millhauser GL
    Biochemistry; 2011 Mar; 50(11):1771-7. PubMed ID: 21319811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the effect of the membrane-mimetic micelles on the interplay between α-synuclein and Cu(II)/Cu(I) cations.
    Uceda AB; Ramis R; Pauwels K; Adrover M; Mariño L; Frau J; Vilanova B
    J Inorg Biochem; 2023 Oct; 247():112344. PubMed ID: 37542850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
    Mori A; Imai Y; Hattori N
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination and redox properties of copper interaction with α-synuclein.
    Valensin D; Dell'Acqua S; Kozlowski H; Casella L
    J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein.
    Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
    Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment.
    Bacchella C; Camponeschi F; Kolkowska P; Kola A; Tessari I; Baratto MC; Bisaglia M; Monzani E; Bubacco L; Mangani S; Casella L; Dell'Acqua S; Valensin D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics.
    Hellstrand E; Grey M; Ainalem ML; Ankner J; Forsyth VT; Fragneto G; Haertlein M; Dauvergne MT; Nilsson H; Brundin P; Linse S; Nylander T; Sparr E
    ACS Chem Neurosci; 2013 Oct; 4(10):1339-51. PubMed ID: 23823878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.
    Rasia RM; Bertoncini CW; Marsh D; Hoyer W; Cherny D; Zweckstetter M; Griesinger C; Jovin TM; Fernández CO
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4294-9. PubMed ID: 15767574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.
    Beyer K
    Cell Biochem Biophys; 2007; 47(2):285-99. PubMed ID: 17652776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossroads between copper ions and amyloid formation in Parkinson's disease.
    Wittung-Stafshede P
    Essays Biochem; 2022 Dec; 66(7):977-986. PubMed ID: 35757906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The density of anionic lipids modulates the adsorption of α-Synuclein onto lipid membranes.
    Andersson A; Linse S; Sparr E; Fornasier M; Jönsson P
    Biophys Chem; 2024 Feb; 305():107143. PubMed ID: 38100855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of α-synuclein oligomers with lipid membranes.
    Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
    Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.